Aug 02, 2017 - The two biopharma giants PD-1 inhibitors are facing off against each other in cancer indications that are worth billions of dollars in annual sales.
Aug 24, 2017 - How does a compound annual growth rate of 50%, 60%, or 70% sound?
Aug 04, 2016 - Immune Design Corp. (IMDZ) is scheduled to report second-quarter 2016 results after the market closes on Aug 9.
Apr 12, 2017 - Bristol-Myers Squibb Company (BMY) announced a collaboration agreement with clinical-stage biopharmaceutical company Apexigen, Inc.
Jun 29, 2017 - A pessimistic look at Merck from an optimist.
Mar 03, 2017 - Quite a few companies including AstraZeneca (AZN) provided pipeline/regulatory updates this week.
Jun 06, 2017 - Merck & Co Inc. (NYSE:MRK) Investor Briefing at 2017 ASCO Annual Meeting Call June 5, 2017 18:45 ET Executives Teri Loxam - Investor Relations Roger Perlmutter - President, Merck Research Labs Fra
Jul 03, 2017 - AstraZeneca, GlaxoSmithKline, and Teva Pharmaceutical Industries sport some of the highest dividend yields among drugmakers today. Here's why their rewards could outweigh their risks.
Sep 18, 2017 - These next-generation medicines are quickly becoming the foundation for advanced cancer treatments.
Jul 15, 2018 - You can buy these three surprising companies before Wall Street catches on. It could pay off with huge returns, too.